General Practice · Glendale, CA
NPI
1174545651
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
908 S Central Ave
Glendale, CA, 91204
Phone (818) 244-6633
Medicare paid, 2024
$469K
7,535 services
Medicare patients, 2024
897
Average age 75
Drug cost, 2024
$5.1M
61,793 prescriptions
Company payments, 2025
$3,570
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zaven M Arslanian was code 99213 (office e&m - established), 6,018 times for 887 patients. In total Zaven M Arslanian billed 7,535 services in 20 codes, and Medicare paid $469K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 6,018 | 887 | $72.73 | $438K |
| 36415 Venipuncture Blood Collection | Office | 747 | 578 | $8.65 | $6,462 |
| 82962 Clinical Chemistry | Office | 328 | 289 | $3.21 | $1,053 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 216 | 84 | $44.02 | $9,509 |
| 93000 Electrocardiogram | Office | 55 | 55 | $12.32 | $678 |
| 99214 Office E&M - Established | Office | 43 | 42 | $104.45 | $4,491 |
| 99203 Office E&M - New | Office | 34 | 34 | $82.22 | $2,796 |
| 99215 Office E&M - Established | Office | 30 | 30 | $110.90 | $3,327 |
| 96372 Injection Administration | Office | 18 | 18 | $12.49 | $225 |
By year: 2022 $573K for 8,618 services; 2023 $536K for 8,245 services; 2024 $469K for 7,535 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 747 | 578 | $8.65 | $6,462 |
| 82962 Clinical Chemistry | 328 | 289 | $3.21 | $1,053 |
Medicare prescription drug claims, 2024
In 2024, the drug Zaven M Arslanian prescribed most often to Medicare patients was Amlodipine Besylate, with 2,088 prescriptions and refills. In total Zaven M Arslanian wrote 61,793 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 2,088 | 2,559 | 259 | $2,834 |
| Simvastatin Generic | 1,597 | 1,919 | 186 | $3,144 |
| Gabapentin Generic | 1,592 | 1,911 | 209 | $5,926 |
| Omeprazole Generic | 1,509 | 1,794 | 198 | $4,093 |
| Levothyroxine Sodium Generic | 1,296 | 1,530 | 137 | $5,033 |
| Diclofenac Sodium Generic | 1,264 | 1,485 | 241 | $209K |
| Meclizine Hcl Generic | 1,167 | 1,422 | 166 | $6,041 |
| Metformin Hcl Generic | 1,127 | 1,435 | 142 | $16K |
| Atorvastatin Calcium Generic | 1,116 | 1,444 | 150 | $3,379 |
| Vascepa Icosapent Ethyl | 1,059 | 1,288 | 155 | $405K |
| Baclofen Generic | 1,054 | 1,405 | 161 | $4,012 |
| Metoprolol Succinate Generic | 961 | 1,246 | 118 | $5,798 |
| Tamsulosin Hcl Generic | 955 | 1,204 | 130 | $4,523 |
| Furosemide Generic | 941 | 1,103 | 125 | $1,715 |
| Montelukast Sodium Generic | 929 | 1,117 | 122 | $3,362 |
Brand drugs: 7,797 claims; generic drugs: 53,242 claims; opioid claims: 129.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zaven M Arslanian $3,570 ($3,570 in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $523.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $523 |
| Amgen Inc. AMGN | 15 | $349 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $303 |
| Ardelyx, Inc. ARDX | 9 | $270 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $238 |
| Lilly USA, LLC LLY | 8 | $185 |
| GlaxoSmithKline, LLC. GSK | 10 | $184 |
| Dexcom, Inc. DXCM | 4 | $168 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $140 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.